Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome–positive acute lymphoblastic leukemia

Author： Shimoni Avichai   Volchek Yulia   Koren-Michowitz Maya   Varda-Bloom Nira   Somech Raz   Shem-Tov Noga   Yerushalmi Ronit   Nagler Arnon  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|6|863-871

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.6, 2015-03, pp. : 863-871

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

By  

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4158-4164

Blackwell Publishing

Access to resources Recommend Favorite

Nilotinib for the treatment of Philadelphia-chromosome-positive chronic myeloid leukemia

By Fullmer Amber   Kantarjian Hagop   Cortes Jorge   Jabbour Elias  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 3065-3072

Informa Healthcare

Access to resources Recommend Favorite

Nilotinib: In the First-Line Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia in Chronic Phase

By Garnock-Jones Karly P.  

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1579-1590

Adis International

Access to resources Recommend Favorite

A review of the clinical and economic outcomes of imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia

By Carpiuc Kimbach T   Stephens Jennifer M   Botteman Marc F   Feng Weiwei   Hay Joel W  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2775-2787

Informa Healthcare

Access to resources Recommend Favorite

Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia

By Jeha Sima   Coustan-Smith Elaine   Pei Deqing   Sandlund John T.   Rubnitz Jeffrey E.   Howard Scott C.   Inaba Hiroto   Bhojwani Deepa   Metzger Monika L.   Cheng Cheng   Choi John K.   Jacobsen Jeffrey   Shurtleff Sheila A.   Raimondi Susana   Ribeiro Raul C.   Pui Ching-Hon   Campana Dario  

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1514-1519

Blackwell Publishing

Access to resources Recommend Favorite